Sponsored by
Very impressive results for GammaTile. For recurrent Glioblastoma patients with methylated MGMT, overall survival reached 37 months. For Unmethylated, survival was 20 months, which is still very impressive!
GammaTile are implantable tiles that release radiation to the tumor bed. They are FDA approved. Since they are relatively new, they are not yet available at all hospitals, so if you are going to have a brain tumor surgery, ask your doctor if GammaTile is appropriate for your case. If he says no, check the https://gammatile.com/findatreatmentcenter/ website to see if your center has experience with GammaTile. If not, get a second opinion from one of the centers listed.